TARGET
saveTIGIT
T-cell immunoreceptor with Ig and ITIM domains; next-gen checkpoint.
also known as: anti-tigit
drugs
0
catalysts
0
news
12
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlightbiopharma dive · 1mo ago
- CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’fiercebiotech · 1mo ago
- AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failurebiospace · 2mo ago
- Summit, Merck must navigate new regulatory terrain in China-first cancer landscapebiospace · 2mo ago
- ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Goonclive · 5mo ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that